p16 Expression as a Surrogate Marker for HPV Infection in Esophageal Squamous Cell Carcinoma can Predict Response to Neo-Adjuvant Chemotherapy. [electronic resource]
Producer: 20160816Description: 7161-5 p. digitalISSN:- 2476-762X
- Adult
- Age Factors
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- analysis
- Carcinoma, Squamous Cell -- chemistry
- Chemotherapy, Adjuvant
- Cyclin-Dependent Kinase Inhibitor p16
- Esophageal Neoplasms -- chemistry
- Female
- Humans
- India -- epidemiology
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Proteins -- analysis
- Papillomavirus Infections -- epidemiology
- Predictive Value of Tests
- Prevalence
- Remission Induction
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.